← All companies
HBIO
Harvard Bioscience, Inc.
$6.31
+0.21 +3.44%
Key statistics
from XBRL data in SEC filingsMarket cap
$28.5M
Revenue (TTM)
$85.5M
Net income (TTM)
-$9.78M
EPS (TTM)
$9.37
P/E ratio
0.7
Dividend yield
—
Free cash flow
$5.47M
Cash
$7.10M
Total assets
$77.9M
Gross margin
58.4%
52-week range
$3.80 – $9.40
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change; Shareholder vote results
Jun 2, 2026
10-Q
Quarter ended 2026-03-31
May 12, 2026
8-K
Regulation FD disclosure
May 12, 2026
8-K
Results of operations (earnings release)
May 12, 2026
8-K
Regulation FD disclosure
Mar 17, 2026
10-K
Fiscal year ended 2025-12-31
Mar 13, 2026
8-K
Results of operations (earnings release)
Mar 12, 2026
8-K
Director or officer change
Mar 10, 2026
8-K
Shareholder vote results; Regulation FD disclosure; Other events
Mar 6, 2026
8-K
Results of operations (earnings release)
Feb 10, 2026
8-K
Exit or disposal costs; Regulation FD disclosure
Jan 29, 2026
8-K
Amended charter or bylaws
Jan 20, 2026
8-K
Regulation FD disclosure
Jan 12, 2026
8-K
Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Director or officer change
Dec 17, 2025
8-K
Other events
Dec 5, 2025
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Results of operations (earnings release)
Nov 6, 2025
8-K
Delisting notice or listing-rule failure
Oct 3, 2025
8-K
Director or officer change; Regulation FD disclosure
Sep 9, 2025
8-K
Director or officer change
Aug 13, 2025
10-Q
Quarter ended 2025-06-30
Aug 11, 2025
8-K
Entered a material agreement
Aug 11, 2025
8-K
Results of operations (earnings release)
Aug 11, 2025
8-K
Director or officer change; Other events
Jul 17, 2025
8-K/A
Delisting notice or listing-rule failure
Jun 27, 2025
8-K
Delisting notice or listing-rule failure
Jun 23, 2025
8-K
Director or officer change
Jun 13, 2025
8-K
Director or officer change; Shareholder vote results
Jun 2, 2025
10-Q
Quarter ended 2025-03-31
May 12, 2025
8-K
Results of operations (earnings release)
May 12, 2025
8-K
Director or officer change
Apr 16, 2025
8-K
Delisting notice or listing-rule failure; Director or officer change; Other events
Apr 10, 2025
10-K
Fiscal year ended 2024-12-31
Mar 14, 2025
8-K
Results of operations (earnings release)
Mar 12, 2025
8-K
Entered a material agreement; Other events
Mar 12, 2025
10-Q
Quarter ended 2024-09-30
Nov 8, 2024
8-K
Results of operations (earnings release)
Nov 7, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release)
Aug 8, 2024
8-K
Shareholder vote results
May 14, 2024